Day Return
YTD Return
1-Year Return
3-Year Return
5-Year Return
Note: Sector performance is calculated based on the previous closing price of all sector constituents
Industries in This Sector
Select an Industry for a Visual Breakdown
| Industry | Market Weight | Day Return | YTD Return |
|---|---|---|---|
| All Industries | 100% | 0.55% | 5.77% |
| Drug Manufacturers - General | 33.85% | 0.30% | 10.89% |
| Healthcare Plans | 13.21% | 0.80% | -2.65% |
| Medical Devices | 12.91% | 0.48% | 7.47% |
| Biotechnology | 11.60% | 1.27% | 0.04% |
| Diagnostics & Research | 11.43% | 0.43% | 5.80% |
| Medical Instruments & Supplies | 6.66% | -0.15% | 6.44% |
| Medical Care Facilities | 2.86% | 0.84% | 11.74% |
| Drug Manufacturers - Specialty & Generic | 2.74% | 0.94% | -3.18% |
| Medical Distribution | 2.39% | 0.88% | 12.77% |
| Health Information Services | 2.07% | 1.44% | 7.74% |
| Pharmaceutical Retailers | 0.27% | -0.31% | -20.86% |
All Industries
-
Note: Percentage % data on heatmap indicates Day Return
Largest Companies in This Sector
Name | Last Price | 1Y Target Est. | Market Weight | Market Cap | Day Change % | YTD Return | Avg. Analyst Rating |
|---|---|---|---|---|---|---|---|
| 771.36 | 801.75 | 11.11% | Buy | ||||
| 491.76 | 594.94 | 6.88% | Buy | ||||
| 156.15 | 175.19 | 5.71% | Buy | ||||
| 178.63 | 183.39 | 4.79% | Buy | ||||
| 121.67 | 134.32 | 4.67% | Buy | ||||
| 582.56 | 596.99 | 3.37% | Buy | ||||
| 113.58 | 125.74 | 2.99% | Buy | ||||
| 252.60 | 260.70 | 2.83% | Buy | ||||
| 27.58 | 32.22 | 2.37% | Buy | ||||
| 271.88 | 283.10 | 2.21% | Buy |
Investing in the Healthcare Sector
Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds
ETF Opportunities
Name | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| 145.43 | 40.661B | 0.09% | ||
| 267.04 | 20.828B | 0.10% | ||
| 94.12 | 7.911B | 0.35% | ||
| 136.13 | 7.64B | 0.45% | ||
| 57.37 | 5.497B | 0.40% |
Mutual Fund Opportunities
Name | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| 216.11 | 47.172B | 0.34% | ||
| 91.13 | 47.172B | 0.34% | ||
| 132.93 | 20.828B | 0.10% | ||
| 92.96 | 15.279B | 0.67% | ||
| 93.21 | 14.712B | 0.80% |
Healthcare Research
Discover the Latest Analyst and Technical Research for This Sector
Analyst Report: ConvaTec Group PLC
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 33% and 29% of total revenue, respectively. Continence care has become a slightly smaller business (21% of revenue) following the decision to exit the acute care market, and infusion sets contribute 17% of consolidated revenue.
RatingNeutralPrice TargetDaily – Vickers Top Insider Picks for 03/19/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Buyers & Sellers for 03/19/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Analyst Report: Teleflex Incorporated
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2023 sales), interventional (17%), anesthesia (13%), surgical (14%), interventional urology (11%), original-equipment manufacturing (11%), and other (10%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
RatingNeutralPrice Target
